ArticleNaunyn-Schmiedeberg's archives of pharmacology2024

Empagliflozin ameliorates liver fibrosis in NASH rat model via targeting hepatic NF-κB/SOX9/OPN signaling and osteocalcin level.

Mohamed M Elseweidy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.